Scholars@Duke

Phase II trial of Gliadel plus 0(6)-benzylguanine (0(6) -BG) for patients with recurrent glioblastoma multiforme.

Publication ,  Conference
Quinn, JA; Vredenburgh, JJ; Rich, JN; Reardon, DA; Desjardins, A; Gururangan, S; Friedman, AH; Lavin, K; Sathornsumetee, S; Threatt, S; Friedman, HS
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 20, 2006
Link to item

Duke Scholars

Henry Seth Friedman
Author Henry Seth Friedman Neurosurgery, Neuro-Oncology

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

June 20, 2006

Volume

24

Issue

18

Start / End Page

74S / 74S

Location

Atlanta, GA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Quinn, J. A., Vredenburgh, J. J., Rich, J. N., Reardon, D. A., Desjardins, A., Gururangan, S., … Friedman, H. S. (2006). Phase II trial of Gliadel plus 0(6)-benzylguanine (0(6) -BG) for patients with recurrent glioblastoma multiforme. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 24, pp. 74S-74S). Atlanta, GA: AMER SOC CLINICAL ONCOLOGY.
Quinn, J. A., J. J. Vredenburgh, J. N. Rich, D. A. Reardon, A. Desjardins, S. Gururangan, A. H. Friedman, et al. “Phase II trial of Gliadel plus 0(6)-benzylguanine (0(6) -BG) for patients with recurrent glioblastoma multiforme.” In JOURNAL OF CLINICAL ONCOLOGY, 24:74S-74S. AMER SOC CLINICAL ONCOLOGY, 2006.
Quinn JA, Vredenburgh JJ, Rich JN, Reardon DA, Desjardins A, Gururangan S, et al. Phase II trial of Gliadel plus 0(6)-benzylguanine (0(6) -BG) for patients with recurrent glioblastoma multiforme. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2006. p. 74S-74S.
Quinn, J. A., et al. “Phase II trial of Gliadel plus 0(6)-benzylguanine (0(6) -BG) for patients with recurrent glioblastoma multiforme.” JOURNAL OF CLINICAL ONCOLOGY, vol. 24, no. 18, AMER SOC CLINICAL ONCOLOGY, 2006, pp. 74S-74S.
Quinn JA, Vredenburgh JJ, Rich JN, Reardon DA, Desjardins A, Gururangan S, Friedman AH, Lavin K, Sathornsumetee S, Threatt S, Friedman HS. Phase II trial of Gliadel plus 0(6)-benzylguanine (0(6) -BG) for patients with recurrent glioblastoma multiforme. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2006. p. 74S-74S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

June 20, 2006

Volume

24

Issue

18

Start / End Page

74S / 74S

Location

Atlanta, GA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences